VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹112 Cr | ₹80 Cr | ₹77 Cr | ₹39 Cr | ₹32 Cr |
What is the latest Sundry Debtors ratio of VENUS REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹112 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹32 Cr |
How is Sundry Debtors of VENUS REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹112 Cr | 39.40 | |
| Mar2024 | ₹80 Cr | 5.01 | |
| Mar2023 | ₹77 Cr | 98.60 | |
| Mar2022 | ₹39 Cr | 20.47 | |
| Mar2021 | ₹32 Cr | - | |
Compare Sundry Debtors of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,237.3 Cr | 11.8% | 38.1% | 208.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 11.8% |
38.1% |
208.2% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses